Phase-II-Studie zur Behandlung progredienter fortgeschrittener niedrig maligner Non-Hodgkin Lymphome mit 2-Chlorodeoxyadenosine (2-CdA)
Primärtherpie oder Therapie nach erstem Rezidiv
We couldn't estimate the reading time for this book.
Word Count
0 words, Guess
Page Count
0 pages
Identifiers
- OCLC Control Number52187083
- Open LibraryOL56992016M
Subjects
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!